Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Yuebing Li MD, PhD

Yuebing Li MD, PhD

Professor, Neurology, and Director, Neuromuscular Center Research, Cleveland Clinic, Cleveland, Ohio

Dr. Yuebing Li is currently a staff neurologist in the Neuromuscular Center at the Cleveland Clinic Foundation, and professor of neurology at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Dr. Li completed his neurology residency at University of Cincinnati in 2002 where he was elected chief resident. This was followed by a one-year fellowship in clinical neurophysiology that was also at the University of Cincinnati. He is board certified in Neurology and Electrodiagnostic Medicine. Dr. Li practiced at Lehigh Valley Physician Group-Lehigh Neurology as a neuromuscular specialist for nine years before joining Cleveland Clinic in 2012.

Dr. Li has published more than 100 articles on neuromuscular medicine and neurology, and received many teaching awards including the award for Neurology Teacher of the Year at Cleveland Clinic in 2014, 2019 and 2020. He has also been voted as best doctors by Best Doctors of America from 2007 to 2022. He was a recipient of the Scientific Impact Award from American Association of Neuromuscular and Electrodiagnostic Medicine in 2020.

Although he has a large practice that includes patients with various neuromuscular disorders, Dr. Li has a special interest in the diagnosis and treatment of myasthenia gravis. He serves as the principal investigator for many investigational myasthenia gravis trials at Cleveland Clinic. He serves as a member of the Medical and Scientific Advisory Board for the Myasthenia Gravis Foundation of America up to 2022. He was a recipient of the Doctor of the Year Award from Myasthenia Gravis Foundation of America and he served as the National Myasthenia Gravis Walk Medical Chair in 2017. In 2018, he was also elected as the National Medical Ambassador of the year by the Myasthenia Gravis Foundation of America organization.

Disclosures

Dr. Li has consulted for Argenx, Catalyst, Immunovant, and UCB Pharma and has received grant support from Argenx.